John Hancock Multifactor Health Care ETF
JHMH
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- MA United States of America
- IPO Date
- Sep 28, 2015
- CIK
- 0001478482
- Similar Companies
- Business
- John Hancock Multifactor Health Care ETF (JHMH) is an exchange-traded fund that seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the John Hancock Dimensional Healthcare Index. The fund invests in public equity markets of the United States, focusing on stocks of companies operating across health care sectors, including health technology and health services; it emphasizes growth and value stocks across diversified market capitalizations, with heavier weighting toward smaller-cap, lower-relative-price, higher-profitability, and higher-momentum securities within the U.S. health care universe whose market capitalizations exceed that of the 1001st largest U.S. health care company. Launched on September 28, 2015, and managed by John Hancock Investment Management LLC (a division of Manulife John Hancock Investments) with co-management by Dimensional Fund Advisors L.P., the ETF was headquartered in Boston, Massachusetts, and targeted institutional and retail investors seeking sector-specific exposure through a multifactor strategy. The fund's portfolio typically comprised around 123 holdings, with significant allocations to health technology (approximately 69%), health services (19%), and smaller portions in distribution services and electronic technology; top holdings represented about 38% of assets, and it maintained an expense ratio of 0.40% with a dividend yield around 0.80-1.62%. Geographically, it focused exclusively on U.S.-domiciled companies (approximately 96%), with minor exposures to Ireland and other regions via holdings. In a major strategic change, the Board of Trustees of John Hancock Exchange-Traded Fund Trust approved the closing and liquidation of JHMH on September 20-22, 2022, determining that continuation was not economically viable due to adverse operational factors. Trading ceased after market close on October 24, 2022, with final liquidating distributions to remaining shareholders on October 26, 2022; the fund was subsequently delisted from NYSE Arca and is no longer active. This action aligned with broader adjustments to John Hancock Investments' ETF lineup, which has since expanded to 17 active funds exceeding $7.8 billion in assets under management as of late 2025, excluding liquidated products like JHMH.